CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma

Erstveröffentlichung
2016Authors
Stracquadanio, Giovanni
Vrugt, Bart
Flury, Renata
Schraml, Peter
Würl, Peter
Wissenschaftlicher Artikel
Published in
Clinical Cancer Research ; 22 (2016), 24. - S. 6069-6077. - ISSN 1078-0432. - eISSN 1557-3265
Link to publication
https://dx.doi.org/10.1158/1078-0432.CCR-16-0058Institutions
UKU. Klinik für Allgemein- und ViszeralchirurgieSubject headings
[Free subject headings]: soft-tissue sarcomas | randomized controlled-trial | long-term survival | radiation-therapy | neoadjuvant chemotherapy | adjuvant chemoradiation | high-grade | body-wall | phase-iii | high-risk[DDC subject group]: DDC 610 / Medicine & health